Citius shareholders defeat share-increase proposal, elect all director nominees

Citius Pharmaceuticals, Inc.

Proposal to raise authorized shares from 26M to 260M failed with 3,222,490 for vs. 1,934,414 against.
All seven director nominees elected; Leonard Mazur received 2,301,986 for, 983,591 withheld.
Advisory vote on executive compensation approved: 1,943,011 for, 1,196,649 against, 1,969,380 broker non-votes.
Ratification of Wolf & Co. as auditor for FY2025 passed with 4,466,905 for, 592,161 against.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.